131 related articles for article (PubMed ID: 24262585)
1. Conditional survival of malignant melanoma in The Netherlands: 1994-2008.
van der Leest RJ; van Steenbergen LN; Hollestein LM; de Vries E; Nijsten T; van Akkooi AC; Janssen-Heijnen ML; Coebergh JW
Eur J Cancer; 2014 Feb; 50(3):602-10. PubMed ID: 24262585
[TBL] [Abstract][Full Text] [Related]
2. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
4. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.
Lindholm C; Andersson R; Dufmats M; Hansson J; Ingvar C; Möller T; Sjödin H; Stierner U; Wagenius G;
Cancer; 2004 Nov; 101(9):2067-78. PubMed ID: 15372475
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic study of 85 cases of melanoma of the female genitalia.
Tcheung WJ; Selim MA; Herndon JE; Abernethy AP; Nelson KC
J Am Acad Dermatol; 2012 Oct; 67(4):598-605. PubMed ID: 22243767
[TBL] [Abstract][Full Text] [Related]
6. Minimal excess mortality for long-term colon cancer survivors in the Netherlands 1989-2008.
van Steenbergen LN; Steur M; Lemmens VE; Rutten HJ; van Spronsen DJ; Janssen-Heijnen ML
Eur J Cancer; 2013 Feb; 49(3):585-92. PubMed ID: 22967727
[TBL] [Abstract][Full Text] [Related]
7. Conditional survival after surgical treatment of melanoma: an analysis of the Surveillance, Epidemiology, and End Results database.
Rueth NM; Groth SS; Tuttle TM; Virnig BA; Al-Refaie WB; Habermann EB
Ann Surg Oncol; 2010 Jun; 17(6):1662-8. PubMed ID: 20165985
[TBL] [Abstract][Full Text] [Related]
8. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
9. Melanoma of unknown primary origin: a population-based study in the Netherlands.
de Waal AC; Aben KK; van Rossum MM; Kiemeney LA
Eur J Cancer; 2013 Feb; 49(3):676-83. PubMed ID: 23031553
[TBL] [Abstract][Full Text] [Related]
10. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?
Gajdos C; Griffith KA; Wong SL; Johnson TM; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
Cancer; 2009 Dec; 115(24):5752-60. PubMed ID: 19827151
[TBL] [Abstract][Full Text] [Related]
11. Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989.
Hollestein LM; van den Akker SA; Nijsten T; Karim-Kos HE; Coebergh JW; de Vries E
Ann Oncol; 2012 Feb; 23(2):524-30. PubMed ID: 21543630
[TBL] [Abstract][Full Text] [Related]
12. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
[TBL] [Abstract][Full Text] [Related]
13. Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit.
McKinnon JG; Yu XQ; McCarthy WH; Thompson JF
Cancer; 2003 Sep; 98(6):1223-31. PubMed ID: 12973846
[TBL] [Abstract][Full Text] [Related]
14. Diversity of stage III melanoma in the era of sentinel lymph node biopsy.
Egger ME; Callender GG; McMasters KM; Ross MI; Martin RC; Edwards MJ; Urist MM; Noyes RD; Sussman JJ; Reintgen DS; Stromberg AJ; Scoggins CR
Ann Surg Oncol; 2013 Mar; 20(3):956-63. PubMed ID: 23064795
[TBL] [Abstract][Full Text] [Related]
15. Thin melanomas: predictive lethal characteristics from a 30-year clinical experience.
Kalady MF; White RR; Johnson JL; Tyler DS; Seigler HF
Ann Surg; 2003 Oct; 238(4):528-35; discussion 535-7. PubMed ID: 14530724
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous malignant melanoma of the head and neck.
Fisher SR
Laryngoscope; 1989 Aug; 99(8 Pt 1):822-36. PubMed ID: 2755292
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in patients with thick cutaneous melanoma (> 4 mm).
Zettersten E; Sagebiel RW; Miller JR; Tallapureddy S; Leong SP; Kashani-Sabet M
Cancer; 2002 Feb; 94(4):1049-56. PubMed ID: 11920475
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
[TBL] [Abstract][Full Text] [Related]
19. The role of sentinel lymph node biopsy in patients with thick melanoma. A single centre experience.
Kelly J; Redmond HP
Surgeon; 2012 Apr; 10(2):65-70. PubMed ID: 22385526
[TBL] [Abstract][Full Text] [Related]
20. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]